Skip to main navigation
WINDTREE THERAPEUTICS logo

Header Nav

  • Company
    • Company Overview
    • Management
    • Board of Directors
    • Corporate Governance
    • Contact Us
    • Diversity, Inclusion and Innovation
  • Pipeline and Technology
    • Pipeline and Therapeutic Overview
    • Istaroxime
    • SERCA2a Activators
    • Lucinactant (KL4 surfactant)
    • AEROSURF®
    • Rostafuroxin
    • Expanded Access Policy
  • Business Development
  • Investors
    • Welcome
    • Financial Information
      • IR Snapshot
      • Annual Reports
    • Financial Fundamentals
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Filings
      • SEC Filings
      • Ownership
    • Corporate Governance
    • Corporate Presentation
    • Events
    • Press Releases
    • Investor Alerts
  • Contact Us
Select Page

Annual Reports

Header Nav

  • Welcome
  • Financial Information
    • IR Snapshot
    • Annual Reports
  • Financial Fundamentals
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
  • Filings
    • SEC Filings
    • Ownership
  • Corporate Governance
  • Corporate Presentation
  • Events
  • Press Releases
  • Investor Alerts

Toolkit

  • Email Alerts
  • Print Page
  • Share
  • RSS Feeds
  • Contact IR
  • Search

Annual Reports

2023 Annual Report - Form 10-K
0001437749-24-012210_Page_001
2023 Annual Report - Form 10-K 3.1 MB
2022 Annual Report - Form 10-K
2022
2022 Annual Report - Form 10-K 2.4 MB
2021 Annual Report - Form 10-K
2021 Annual Report - Form 10-K
2021 Annual Report - Form 10-K 1.2 MB
2020 Annual Report - Form 10-K
2020 Annual Report - Form 10-K
2020 Annual Report - Form 10-K 1.1 MB
2019 Annual Report - Form 10-K
2019 Annual Report - Form 10-K
2019 Annual Report - Form 10-K 1.3 MB
2018 Annual Report - Form 10-K
2018 Annual Report - Form 10-K
2018 Annual Report - Form 10-K 898.9 KB
YM Twitter Feed
© Copyright 2024 Windtree Therapeutics, Inc